NCT06793579Completed
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
Thyroid Cancer Superior Mediastinal Lymph Node Dissection Via Lateral Cervical Approach: Exploration and Practice of a Novel Surgical Pathway
Source: ClinicalTrials.gov · Last updated 27 Jan 2025
Brief summary (registry, in English)
Despite the numerous surgical approaches available for superior mediastinal lymph node dissection in thyroid cancer, many of these methods still have significant limitations. In this study, we report for the first time a novel surgical technique for superior mediastinal lymph node dissection: a thyroid cancer surgery based on a lateral cervical approach. This technique offers a new surgical option for the dissection of superior mediastinal lymph nodes in thyroid cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 21 (actual)
- First submitted
- 21 Jan 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 20 Jan 2025
- Lead sponsor
- Chongqing General Hospital
- Diseases
- Thyroid cancer, Childhood cancers
- NCT number
- NCT06793579
What you commit to
- Study type: Observational
- Participants enrolled: 21
- From 1 Jan 2024 to the primary completion date, 20 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Systemic diseases with severe heart, lung, liver, kidney, or brain dysfunction that may affect the accuracy of data.
- Tumor pathology indicating undifferentiated thyroid cancer, malignant lymphoma, or non-thyroid-origin tumors.
Other
- Cases with incomplete data, such as missing hospitalization records or incomplete follow-up data.
- Patients with severe coagulopathy.
Who the study is looking for
- All patients who underwent thyroid cancer superior mediastinal lymph node dissection via the lateral cervical approach in our department.
- Complete hospitalization records, ensuring that the patient's surgical records, pathological examinations, and other information are fully traceable.
- Complete postoperative follow-up data, including complications during the follow-up period.
- No other severe comorbidities, to avoid surgical outcome bias caused by other diseases.
- No distant metastasis found preoperatively, or distant metastasis is still assessable for effective treatment.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chongqing General Hospital Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.